Objective: To evaluate whether acute elevations of local plasma glucose concentrations could influence forearm blood flow (FBF) and how this interacts with local hyperinsulinaemia in healthy volunteers. Methods: Using the perfused forearm technique, in random order, glucose 20% or saline 0.9% as a control was infused in three dose steps (0.3, 1.0, and 3.0 ml/min) for 5 min each in eight healthy men. The infusion experiments were repeated, in random order, during local hyperinsulinaemia by intra-arterial infusion of insulin 0.05 mU/kg/min. The ratio of FBF of the infused over the FBF in the control arm (FR) was measured at 15-sec intervals during the infusions. Results: Glucose infusion increased the FR dosedependently by 172% ± 39% (M ± SE) at the highest dose (P Ͻ 0.01). During hyperinsulinaemia the glucoseinduced increase in FR was significantly (P Ͻ 0.01) less, 96% ± 26%, however, when changes in FR or forearm
Introduction
In syndrome X cardiovascular morbidity and mortality are increased, mainly due to the clustering of simultaneously occurring atherosclerotic risk factors in the same individual. 1, 2 The syndrome is characterised by peripheral insulin resistance, dyslipidaemia, obesity, and hypertension. The etiology of the syndrome is poorly understood, however hyperinsulinaemia/insulin resistance and hyperglycaemia seem to play a central role. The acute vascular effect of insulin in healthy men is vasodilation by stimulation of nitric oxide production and secondarily by stimulation of vasodilating prostaglandins. 3, 4 Early in the course of insulin-dependent diabetes mellitus (IDDM), before the occurrence of overt retinopathy, a decrease in retinal blood flow is present that correlates with plasma glucose levels. 5 In contrast, in IDDM with poor metabolic control, elevated cardiac output and forearm blood flow Correspondence: Dr PC Chang, Department of Nephrology, C3-P, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands Received 9 July 1998; revised and accepted 19 October 1998 vascular resistance were related to the plasma glucose concentrations both glucose infusions were equipotent. The saline infusions induced small increases in FR of 27 ± 5% (P Ͻ 0.01) and 24 ± 11% (P Ͼ 0.05), without or with insulin respectively. The changes in FR during the saline infusions were much smaller than during the glucose infusions (P Ͻ 0.01). During the glucose infusions small but significant increases in FBF and venous plasma glucose in the non-infused forearm appeared, indicating carry-over effect and the possibility of a very low threshold for glucose-induced vascular effects. Conclusions: High, local levels of glucose in the forearm have a vasodilator effect on resistance vessels in skeletal muscle of the forearm that is not modified by local hyperinsulinaemia. Indications were found that the threshold for this glucose-induced vasodilation may be remarkably low, but this needs to be studied more formally.
(FBF) was observed. 6 Hyperglycaemia seems to be important because most parameters normalise after the normalisation of metabolic control. 6 The acute effect of hyperglycaemia in combination with acute hyperinsulinaemia on vascular tone in humans is largely unknown. Most experimental studies suggest that hyperglycaemia has vasoconstrictive effects via several mechanisms like: a reduction in the production of nitric oxide, 7 generation of reactive oxygen species, 8 production of vasoconstrictive prostanoids, 9 formation of advanced glycosylation endproducts, 10 and release of endothelin. 11 Therefore, we reasoned that hyperglycaemia itself may induce vasoconstriction and reduce the vasodilating effect of insulin.
In the present study the effect of acute local hyperglycaemia and hyperinsulinaemia were investigated in the forearm vascular bed of healthy male volunteers. To correct for eventual volume effects of the infusions, control experiments with saline were performed.
Subjects and methods
Eight normotensive, healthy, and lean (except one), men after giving informed consent, were investi-gated. Their medical history, physical examination, and routine laboratory tests showed no evidence of diabetes, cardiovascular or other diseases. Their age was 22.5 ± 0.9 years (M ± SE, range 19-28), body mass index 22.8 ± 1.0 kg/m 2 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , serum cholesterol 5.0 ± 0.4 mmol/l (3.9-7.1), and HbA 1c 5.0 ± 0.1% (4.5-5.3). None of the subjects took any medication for at least 2 weeks before the study. The subjects were instructed to refrain from smoking cigarettes or drinking alcohol or caffeine-containing beverages for at least 12 h before the experiment. All tests were conducted in the morning after an overnight fast. The Medical Ethics Committee of the Leiden University Medical Center approved the protocol of the study.
Procedures
All experiences were performed in a quiet room, at a temperature between 22°C and 24°C. During the experiments the subjects were in the supine position with both forearms stabilised slightly above the level of the heart. In both forearms a deep antecubital vein was cannulated for drawing of blood samples and after local anaesthesia of the skin (lignocaine 1%) the brachial artery of the non-dominant arm was cannulated in the cubital fossa. The cannula (Autocath 1453.13, Plastimed, Saint-Leu-laForet, France) was used for infusion of drugs with a Harvard constant rate infusion pump (Harvard-22, Harvard Apparatus Ltd, Kent, UK) and for intraarterial (i.a.) recording of the blood pressure with a Statham P23 Id pressure transducer (Gould Inc, CA, USA). Heart rate was derived from a continuously recorded one-lead electrocardiogram. FBF in both arms was measured semi-continuously at 15-sec intervals by a computerised, R-wave triggered venous occlusion plethysmograph, 12, 13 with collecting cuff inflation to 40 mm Hg during four heartbeats (Hokanson EC-2 plethysmograph, Hokanson Inc, WA, USA), using mercury-in-silastic strain gauges and a rapid cuff inflator (Hokanson E-10), and expressed as milliliters of blood flow per deciliter forearm tissue per minute (ml/dl/min). Forearm vascular resistance (FVR) was derived from the ratio of each FBF measurement and the simultaneously measured i.a. blood pressure. Because hand blood flow consists mainly of skin perfusion with many arterio-venous anastomoses and to ensure stable arterial concentrations, hand blood flow was excluded continuously from the circulation during each experiment using a small wrist cuff inflated to at least 40 mm Hg above systolic blood pressure. Forearm volume was determined by water displacement before the study. The experiments started at least 45 min after the cannulations.
Study protocol
In random order, either first saline 0.9% was infused in cumulative-dose steps of 0.3, 1.0, and 3.0 ml/min for 5 min per dose ('saline control infusion experiment'), or glucose 20% in cumulative-dose steps of 0.3, 1.0, and 3.0 ml/min for 5 min per dose ('glucose infusion experiment').
Subsequently, a continuous i.a. infusion of insulin 0.05 mU/kg/min was started to induce local hyperinsulinaemia and 1 and 2 h later, in random order, the saline and the glucose infusion experiments were repeated.
Between infusions, intervals of at least 40 min were allotted to let FBF return to baseline before initiating a new infusion experiment.
Venous blood samples, from the infused and the non-infused arm, and arterial blood samples from the infused arm, were drawn for determination of plasma insulin and glucose.
Drug solutions, sample collection and assay
Human insulin (Actrapid ™ , NOVO Nordisk Farma, Zoeterwoude, The Netherlands) was aseptically prepared from sterile stock solution and dissolved in 0.9% saline immediately before use. Blood samples were collected into ice-chilled, heparinized tubes. Samples were centrifuged at 4°C and 3500 g for 15 min and the plasma removed and stored at −75°C until assayed. Plasma insulin was measured by radio-immunoassay (MedGenix, Fleures, Belgium). Intra-and interassay variation was less than 5% at all levels. Plasma glucose was determined using standard autoanalyser techniques.
Analysis
To compensate for eventual changes in systemic haemodynamics the ratio of the FBF in the infused arm over the FBF in the control arm was used (forearm blood flow ratio, FR). Averages of six measurements made during the last 2 min of every dose step were used for further analysis.
Arterial plasma concentration of insulin or glucose (C plasma ) was calculated from the infusion rate (IR), haematocrit (Ht), forearm volume (V, in dl), forearm blood flow (FBF, in ml/dl/min), and molecular weight (MW in Dalton) as:
14 Results are presented as means ± s.e.m. A P value less than 0.05 defined statistical significance. Differences between the baseline value and serial repeated measurements were evaluated employing two-way analysis of variance on the measured values with post hoc Scheffé's testing.
Results
During all experiments no significant changes in mean arterial pressure or heart rate occurred. In Table 1 the forearm blood flow, forearm blood flow ratio, and forearm vascular resistance values of the infused (i) and the non-infused (ni) forearms are given.
In the non-infused arm inconsistent vascular effects occurred during the four infusion experiments. Forearm blood flow increased significantly while forearm vascular resistance did not change significantly in the non-infused arm during the infusion of glucose contra-laterally (see Table 1 ). The i.a. infusion of insulin increased the baseline blood flow in the infused arm with around 65% (P Ͻ 0.05, Table 1 ), and increased the FR (P Ͻ 0.05, Table 1 ). There were no significant residual effects of the first infusion (saline/glucose) on the second (glucose/saline), both before as well as during the i.a. insulin infusion.
Saline infusion experiment
During the infusion of saline 3.0 ml/min the FR increased from a baseline value of 1.22 ± 0.20 to 1.59 ± 0.28 (P Ͻ 0.01, Table 1 ), FBF increased from 3.70 ± 0.50 to 5.09 ± 0.78 ml/dl/min (P Ͻ 0.01, Table  1 ), and FVR decreased from 24.1 ± 3.3 to 18.6 ± 2.8 mmHg/ml/dl/min (P Ͻ 0.01, Table 1 ). In the noninfused arm the FBF and FVR did not change significantly. Plasma glucose and insulin values did not change significantly (Table 2) .
Glucose infusion experiment
The FR of the infused arm increased dose-dependently from a baseline value of 1.07 ± 0.13 to 2.64 ± 0.35 at the glucose infusion rate of 3.0 ml/min (P Ͻ 0.01, Table 1 and Figure 1 ), FBF increased from 3.35 ± 0.60 to 9.35 ± 1.27 ml/dl/min (P Ͻ 0.01, Table  1 ). FVR also changed dose-dependently (P Ͻ 0.01, Table 1 , Figure 2 ). Compared to the single saline infusion the changes in FBF as well as in FR and FVR were significantly greater (P Ͻ 0.01, P Ͻ 0.01, P Ͻ 0.05 respectively). Plasma insulin levels did not change significantly and plasma glucose levels changed as expected (Table 2) .
Interestingly, the FBF of the non-infused arm increased from 3.16 ± 0.32 to 3.71 ± 0.49 ml/dl/min (P Ͻ 0.05, see Table 1 ) by the end of the highest dose of glucose, accompanied by a significant increment in the venous plasma glucose and unchanged venous plasma insulin in the non-infused arm (Table 2 ).
Saline infusion experiment during i.a. insulin
As a consequence of the insulin infusion the baseline FBF was increased from 3.70 to 6.08 ml/dl/min (P Ͻ 0.05, Table 1 ) and the FR was increased to 2.04 ± 0.46 (P Ͻ 0.05, Table 1 ). The highest saline infusion rate increased FBF from 6.08 ± 0.99 to 8.27 ± 1.58 ml/dl/min (P Ͻ 0.05, Table 1 ), however, FR and FVR changes were not significant. Compared to the single glucose infusion the changes in FR as well as in FBF and FVR were significantly smaller (all P Ͻ 0.01).
The arterial plasma glucose and insulin values are presented in Table 2 . The infused forearm venous plasma insulin level was increased by the i.a. insulin infusion from a baseline level around 9 mU/L to 73.7 ± 33.4 mU/L (see Table 2 ). The infused forearm venous plasma glucose level did not change significantly (see Table 2 ).
Glucose infusion experiment during i.a. insulin
The i.a. infusion of insulin increased baseline FBF from 3.35 ± 0.60 to 5.62 ± 1.10 ml/dl/min (P Ͻ 0.05, Table 1 ), decreased the FVR to 18.5 ± 4.0 (P Ͻ 0.05, Table 1 ), while the change in FR was not significant. The glucose infusion increased FBF in the infused arm from 5.62 ± 1.10 to 11.10 ± 1.02 ml/dl/min (P Ͻ 0.01, Table 1), the FVR decreased from 18.5 ± 4.0 to 8.5 ± 1.7 mmHg/ml/dl/min (P Ͻ 0.01, Table 1 ) and Table 2 Arterial and venous plasma insulin and glucose in the infused (i) and non-infused (ni) forearm the FR increased from 1.66 ± 0.44 to 2.78 ± 0.59 (P Ͻ 0.01, Table 1 ).
Experiment
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In the infused arm, the arterial and venous plasma levels of insulin and glucose changed as expected (Table 2) . Also in this glucose infusion the FBF of the non-infused arm was increased by the end of the highest dose of glucose from 4.02 ± 0.57 to 5.14 ± 0.90 ml/dl/min (P Ͻ 0.05, Table 1 ) together with a small but significant increase in venous plasma glucose and insulin (P Ͻ 0.01 and P Ͻ 0.05, Table 2 ). Compared to the infusion of saline during insulin i.a. the changes in FR, FBF, and FVR in the infused arm were significantly greater (all P Ͻ 0.01), while compared to the single glucose infusion the changes in FR, FBR, and FVR were comparable. 
Discussion
In this study we examined the effect of acute local hyperglycaemia with and without local hyperinsulinaemia on forearm vascular tone. Acute hyperglycaemia, locally reaching supraphysiological concentrations of glucose, increased forearm blood flow significantly. At the highest dose of glucose a small volume effect of the infusate was probably present as the same infusate volume of 3 ml/min in the saline control infusions induced a small increment in forearm flow. The glucose-induced vasodilation was not modified by concomitant hyperinsulinaemia. The forearm blood flow ratio dose-dependently increased by the glucose infusions and at first instance this effect appeared to be greater without than with local hyperinsulinaemia (see Figure 1) . When depicted as percent change in forearm vascular resistance versus plasma glucose concentration, however, it becomes clear that the glucose-induced vasodilation with or without hyperinsulinaemia has the same order of magnitude, especially when compared to the arterial glucose concentrations reached during the infusions (see Figure 2) . The reason for the seemingly greater effect of glucose on the forearm blood flow ratio before than during the local hyperinsulinaemia (Figure 1 ), is that insulin increased the baseline forearm blood flow level and therefore the same dose of glucose yielded a lower concentration locally.
Interestingly, in the non-infused arm also a, albeit small, vasodilation seemed to have occurred during the glucose infusions, concomitantly with small but significant increases in venous plasma glucose and insulin in the non-infused arm. This suggests that small changes in systemic glucose concentrations may already induce vascular effects. However, forearm vascular resistance in the non-infused arm did not significantly change during the glucose infusion and the number of subjects studied was relatively small. Therefore, no firm conclusion can be drawn on this aspect from this study. In line with our findings, Houben et al 15 also described that a mild hyperglycaemia (venous plasma glucose in the infused forearm of 8 mmol/l) induced by intraarterially infused glucose 20% acutely increased the forearm blood flow. In healthy male volunteers acute systemic hyperglycaemia with venous plasma glucose concentration reaching 15 mmol/l induced significant increments in blood pressure, heart rate, and catecholamine levels which was attributed to scavenging of nitric oxide (NO) via the induction of reactive oxygen species. 16 From our concentrationresponse analysis it seems that at a venous plasma glucose concentration of 15 mmol/L a 20% decrease in forearm vascular resistance occurs (see Figure 1) . If this would occur in the whole body during systemic hyperglycaemia baroreceptor-mediated compensatory reflexes would be recruited. A more formal study on the threshold for vascular effects of glucose therefore seems to be of interest.
Does glucose induce vasodilation or vasoconstriction?
In this study acute hyperglycaemia clearly induced vasodilation. Most studies on glucose-induced vascular effects, however, point towards vasoconstriction. The reason for this apparent discrepancy probably is the time-course at which glucose's vascular effects are studied. For example, Houben et al 15 found in healthy volunteers that after 20 min of mild hyperglycaemia (venous plasma glucose in the infused forearm of 8 mmol/l) forearm blood flow was increased, while in other experiments after 60 min, 15 7 h, 17 or 24 h 18 of moderate hyperglycaemia forearm blood flow changes did not differ from responses to control saline infusions. In experimental studies blood vessels have usually been investigated after at least 60-min incubation at high glucose concentrations, and mainly impaired vasodilator responses were observed. [8] [9] [10] [11] The type of vascular bed studied is also an important determinant. In human retinal blood vessels hyperglycaemia acutely reduces blood flow, 5 while in diabetic children chronically elevated blood glucose levels are associated with retinal vasodilation that precedes the development of overt diabetic retinopathy. 19 In rat intestinal arterioles topical hyperglycaemia for 1 h suppresses NO production, probably by inducing reactive oxygen species formed in part by increases in eicosanoid synthesis, 20 while in the same model after 4 -5 weeks of intermittent increases in intraperitoneal glucose concentration vasodilation is present. 21 The effect of hyperglycaemia on NO production is variable. Several investigators have presented evidence that hyperglycaemia reduces NO availability. 7, 16, 22, 23 Others observed no effect on NO production 18 or even the opposite, namely that hyperglycaemia may in fact stimulate the production of NO. 24, 25 There is no doubt that the induction of systemic hyperglycaemia in healthy lean and obese men results in increases of leg blood flow. 26 In view of the literature findings discussed, it seems that hyperglycaemia acutely induces vasodilation in the peripheral resistance vessels of the forearm and leg. The mechanism of this acute, glucose-induced vasodilation was not investigated in this study. Acutely, it seems that glucose may stimulate the production of nitric oxide, 24, 25 however, it may also act indirectly via increased production of insulin. Longer lasting high glucose levels may reduce vascular tone via several mechanisms like, reduced production of nitric oxide, 7 generation of reactive oxygen species, 8 production of vasoconstrictive prostanoids, 9 formation of advanced glycosylation end-products, 10 or release of endothelin. 11 In experimental studies these mechanisms may be easier to demonstrate than in vivo and especially in men where many homeostasis-regulating systems may counteract the effects of longer lasting periods of hyperglyceaemia.
In conclusion, acute local hyperglycaemia acts vasodilatory in the resistance vessels of the skeletal muscle of the forearm via a yet unknown direct vascular action and indirectly probably via the increased production of insulin. Local hyperinsulinaemia does not modify this glucose-induced vasodilation. Indications were found that small changes in systemic glucose may already induce vasodilation, but this needs to be studied formally.
